CX-2029
CTMX-M-2029-001
Phase 2 small_molecule completed
Quick answer
CX-2029 for Solid Tumor, Adult is a Phase 2 program (small_molecule) at CytomX Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CytomX Therapeutics
- Indication
- Solid Tumor, Adult
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed